ASX - By Stock
|
LTP |
Re:
Ann: Suspension from Quotation
|
|
Apocalypso
|
30 |
9.6K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
30
|
9.6K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Apocalypso
|
327 |
106K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
327
|
106K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Apocalypso
|
380 |
130K |
4 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
130K
|
4
|
|
ASX - By Stock
|
TYP |
Re:
PSYCHEDELICS Tryp Therapeutics and Exopharm Limited Sign Definitive Agreement
|
|
Apocalypso
|
14 |
12K |
4 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
14
|
12K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
Apocalypso
|
91 |
25K |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
91
|
25K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Apocalypso
|
36 |
8.7K |
0 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
36
|
8.7K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
Apocalypso
|
218 |
74K |
3 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
218
|
74K
|
3
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Financial improvements continue
|
|
Apocalypso
|
4 |
1.3K |
0 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Appoints Dr John Byon as SVP Clinical Development
|
|
Apocalypso
|
63 |
25K |
1 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
63
|
25K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
PLEASE EXPLAIN Jackie Fairley !
|
|
Apocalypso
|
6 |
2.9K |
2 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
6
|
2.9K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Apocalypso
|
25K |
12M |
7 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
25K
|
12M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Apocalypso
|
907 |
286K |
3 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
907
|
286K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Apocalypso
|
907 |
286K |
6 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
907
|
286K
|
6
|
|
ASX - By Stock
|
TYP |
Codiak
|
|
Apocalypso
|
3 |
1.8K |
3 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
3
|
1.8K
|
3
|
|
ASX - By Stock
|
TYP |
Re:
movement at the station
|
|
Apocalypso
|
12 |
6.9K |
1 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
12
|
6.9K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Would love to hear from some long termers
|
|
Apocalypso
|
12 |
4.8K |
1 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
12
|
4.8K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm Shareholder Update - Revenue Focus in 2021
|
|
Apocalypso
|
153 |
61K |
2 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
153
|
61K
|
2
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Operations review, Board and other changes
|
|
Apocalypso
|
13 |
6.7K |
5 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
13
|
6.7K
|
5
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Operations review, Board and other changes
|
|
Apocalypso
|
13 |
6.7K |
3 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
13
|
6.7K
|
3
|
|
ASX - By Stock
|
TYP |
Re:
Ann: EX1 to Receive $0.96m in Prepayment of R&D Tax Incentive
|
|
Apocalypso
|
43 |
14K |
2 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
43
|
14K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Apocalypso
|
213 |
75K |
2 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
213
|
75K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Apocalypso
|
213 |
75K |
4 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
213
|
75K
|
4
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Upcoming Conference Presentation ANZSEV2022
|
|
Apocalypso
|
16 |
9.3K |
2 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
16
|
9.3K
|
2
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Change in substantial holding
|
|
Apocalypso
|
2 |
1.1K |
5 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
2
|
1.1K
|
5
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Business Update
|
|
Apocalypso
|
42 |
17K |
1 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
42
|
17K
|
1
|
|
ASX - By Stock
|
TYP |
Rooster and ExoPharm
|
|
Apocalypso
|
2 |
1.2K |
0 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
2
|
1.2K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Apocalypso
|
17 |
7.6K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
17
|
7.6K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Apocalypso
|
17 |
7.6K |
5 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
17
|
7.6K
|
5
|
|
ASX - By Stock
|
TYP |
Re:
Oh Dear!
|
|
Apocalypso
|
6 |
2.2K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
6
|
2.2K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Business Update
|
|
Apocalypso
|
42 |
17K |
6 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
42
|
17K
|
6
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Change in substantial holding
|
|
Apocalypso
|
21 |
9.7K |
3 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
21
|
9.7K
|
3
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Response to ASX Query
|
|
Apocalypso
|
3 |
1.9K |
1 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
3
|
1.9K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Clarification on Exopharm AIRM MSA Announcement
|
|
Apocalypso
|
14 |
4.7K |
2 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
14
|
4.7K
|
2
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm Gains US Patent for LEAP Technology
|
|
Apocalypso
|
24 |
11K |
2 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
24
|
11K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change in substantial holding - PH
|
|
Apocalypso
|
49 |
31K |
1 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
49
|
31K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm welcomes Dr Reiter from bene pharmaChem to the team
|
|
Apocalypso
|
26 |
8.9K |
4 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
26
|
8.9K
|
4
|
|
ASX - By Stock
|
SPL |
Tone deaf Board of Directors?
|
|
Apocalypso
|
7 |
1.9K |
14 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
7
|
1.9K
|
14
|
|
ASX - By Stock
|
TYP |
Tell me another one....
|
|
Apocalypso
|
0 |
417 |
0 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
0
|
417
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Complete Regression of TNBC Tumours and Protective Immunity
|
|
Apocalypso
|
279 |
126K |
6 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
279
|
126K
|
6
|
|
ASX - By Stock
|
TYP |
Objectivity required
|
|
Apocalypso
|
7 |
2.5K |
0 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
7
|
2.5K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm LEAP Technology - Second Commercial Collaboration
|
|
Apocalypso
|
76 |
23K |
4 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
76
|
23K
|
4
|
|
ASX - By Stock
|
PAR |
COO Disclosure
|
|
Apocalypso
|
4 |
2.1K |
1 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
4
|
2.1K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Ann: FY2021 Appendix 4E and Annual Report
|
|
Apocalypso
|
55 |
13K |
2 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
55
|
13K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
Apocalypso
|
150 |
60K |
1 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
150
|
60K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Update - Partnering & Licensing Focus Continues
|
|
Apocalypso
|
28 |
8.7K |
5 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
28
|
8.7K
|
5
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Investor Presentation
|
|
Apocalypso
|
23 |
6.7K |
1 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
23
|
6.7K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Investor Presentation
|
|
Apocalypso
|
23 |
6.7K |
2 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
23
|
6.7K
|
2
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Investor Presentation
|
|
Apocalypso
|
23 |
6.7K |
1 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
23
|
6.7K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
NOX featured in ABR today
|
|
Apocalypso
|
6 |
2.6K |
3 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
6
|
2.6K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: IND QUESTIONS RECEIVED FROM US FDA
|
|
Apocalypso
|
389 |
123K |
2 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
389
|
123K
|
2
|
|